The WACC of Induction Healthcare Group PLC (INHC.L) is 7.4%.
Range | Selected | |
Cost of equity | 5.8% - 9.0% | 7.4% |
Tax rate | 5.6% - 8.4% | 7% |
Cost of debt | 7.0% - 7.0% | 7% |
WACC | 5.8% - 8.9% | 7.4% |
Category | Low | High |
Long-term bond rate | 4.0% | 4.5% |
Equity market risk premium | 6.0% | 7.0% |
Adjusted beta | 0.31 | 0.57 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 5.8% | 9.0% |
Tax rate | 5.6% | 8.4% |
Debt/Equity ratio | 0.01 | 0.01 |
Cost of debt | 7.0% | 7.0% |
After-tax WACC | 5.8% | 8.9% |
Selected WACC | 7.4% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
INHC.L | Induction Healthcare Group PLC | 0.01 | -0.77 | -0.77 |
ALMDT.PA | Median Technologies SA | 0.44 | -0.45 | -0.32 |
COG.L | Cambridge Cognition Holdings PLC | 0 | 1.02 | 1.02 |
FRISQ.ST | Frisq Holding AB (publ) | 0.14 | 0.73 | 0.65 |
MDA.WA | Medapp SA | 0.01 | 0.62 | 0.61 |
NXU.DE | Nexus AG | 0.02 | 0.19 | 0.18 |
SDT.PA | Visiodent SA | 0.19 | -0.21 | -0.18 |
SENS.L | Sensyne Health PLC | 1.63 | 0.16 | 0.06 |
SNT.WA | Synektik SA | 0.01 | 0.63 | 0.62 |
MITI | Mitesco Inc | 0.43 | -1.06 | -0.76 |
Low | High | |
Unlevered beta | -0.03 | 0.35 |
Relevered beta | -0.03 | 0.36 |
Adjusted relevered beta | 0.31 | 0.57 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for INHC.L:
cost_of_equity (7.40%) = risk_free_rate (4.25%) + equity_risk_premium (6.50%) * adjusted_beta (0.31) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.